Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

Saved in:
Bibliographic Details
Title: Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.
Authors: Klonoff DC (AUTHOR), Buse JB (AUTHOR), Nielsen LL (AUTHOR), Guan X (AUTHOR), Bowlus CL (AUTHOR), Holcombe JH (AUTHOR), Wintle ME (AUTHOR), Maggs DG (AUTHOR), Klonoff, David C1 (AUTHOR), Buse, John B (AUTHOR), Nielsen, Loretta L (AUTHOR), Guan, Xuesong (AUTHOR), Bowlus, Christopher L (AUTHOR), Holcombe, John H (AUTHOR), Wintle, Matthew E (AUTHOR), Maggs, David G (AUTHOR)
Source: Current Medical Research & Opinion. Jan2008, Vol. 24 Issue 1, p275-286. 12p.
Database: Academic Search Ultimate
Description
ISSN:03007995
DOI:10.1185/030079907x253870